Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.52 |
| ▸ | UTS2R | Q9UKP6 | 5/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 7/20 | 0.43 |
| ▸ | CASR | P41180 | 1/20 | 0.42 |
| ▸ | FPR2 | P25090 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5570302 | 0.96 | SLC6A2 (0.48) | CNR1UTS2RSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5570583 | 0.90 | CNR1 (0.50) | CNR1UTS2RMAPTEPHX2EP300 | |
| SCHEMBL5570735 | 0.90 | EPHX2 (0.53) | CNR1UTS2RMAPTEPHX2EP300 | |
| SCHEMBL5570803 | 0.87 | F10 (0.40) | CNR1UTS2RSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5565619 | 0.83 | CNR1 (0.51) | CNR1MAPTEPHX2EP300CASR | |
| SCHEMBL5670025 | 0.82 | F10 (0.53) | CNR1SLC6A2SLC6A4SLC6A3EP300 | |
| SCHEMBL5671937 | 0.79 | CNR1 (0.46) | CNR1UTS2RMAPTEP300CASR | |
| SCHEMBL5569345 | 0.79 | OPRM1 (0.46) | CNR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5670191 | 0.78 | MAPT (0.45) | CNR1UTS2RMAPTEP300CASR | |
| SCHEMBL5565655 | 0.78 | F10 (0.39) | CNR1SLC6A2SLC6A4SLC6A3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7250415-B2 | 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-31 | — | — | US | disclosed |
| EP-1628668-A2 | 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS | Bristol-Myers Squibb Company (US) | 2006-03-01 | — | — | EP | disclosed |
| WO-2004108892-A2 | 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-12-16 | — | — | WO | disclosed |